614 related articles for article (PubMed ID: 27059350)
1. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.
Leshem E; Givon-Lavi N; Tate JE; Greenberg D; Parashar UD; Dagan R
Clin Infect Dis; 2016 May; 62 Suppl 2():S155-60. PubMed ID: 27059350
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
Payne DC; Boom JA; Staat MA; Edwards KM; Szilagyi PG; Klein EJ; Selvarangan R; Azimi PH; Harrison C; Moffatt M; Johnston SH; Sahni LC; Baker CJ; Rench MA; Donauer S; McNeal M; Chappell J; Weinberg GA; Tasslimi A; Tate JE; Wikswo M; Curns AT; Sulemana I; Mijatovic-Rustempasic S; Esona MD; Bowen MD; Gentsch JR; Parashar UD
Clin Infect Dis; 2013 Jul; 57(1):13-20. PubMed ID: 23487388
[TBL] [Abstract][Full Text] [Related]
3. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.
Payne DC; Selvarangan R; Azimi PH; Boom JA; Englund JA; Staat MA; Halasa NB; Weinberg GA; Szilagyi PG; Chappell J; McNeal M; Klein EJ; Sahni LC; Johnston SH; Harrison CJ; Baker CJ; Bernstein DI; Moffatt ME; Tate JE; Mijatovic-Rustempasic S; Esona MD; Wikswo ME; Curns AT; Sulemana I; Bowen MD; Gentsch JR; Parashar UD
Clin Infect Dis; 2015 Dec; 61(12):1792-9. PubMed ID: 26449565
[TBL] [Abstract][Full Text] [Related]
4. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.
Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R
Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala.
Gastañaduy PA; Contreras-Roldán I; Bernart C; López B; Benoit SR; Xuya M; Muñoz F; Desai R; Quaye O; Tam KI; Evans-Bowen DK; Parashar UD; Patel M; McCracken JP
Clin Infect Dis; 2016 May; 62 Suppl 2():S121-6. PubMed ID: 27059345
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
Doll MK; Buckeridge DL; Morrison KT; Gagneur A; Tapiero B; Charest H; Quach C
Vaccine; 2015 Dec; 33(51):7307-7314. PubMed ID: 26546262
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
Muhsen K; Anis E; Rubinstein U; Kassem E; Goren S; Shulman LM; Ephros M; Cohen D
Clin Microbiol Infect; 2018 Jan; 24(1):53-59. PubMed ID: 28442435
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
Araki K; Hara M; Tsugawa T; Shimanoe C; Nishida Y; Matsuo M; Tanaka K
Vaccine; 2018 Aug; 36(34):5187-5193. PubMed ID: 30037664
[TBL] [Abstract][Full Text] [Related]
12. Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.
Bonkoungou IJO; Aliabadi N; Leshem E; Kam M; Nezien D; Drabo MK; Nikiema M; Ouedraogo B; Medah I; Konaté S; Ouédraogo-Traoré R; Sangaré L; Kam L; Yé D; Ouattara M; Biey JN; Mwenda JM; Tate JE; Parashar UD
Vaccine; 2018 Nov; 36(47):7170-7178. PubMed ID: 29290478
[TBL] [Abstract][Full Text] [Related]
13. Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses.
Bar-Zeev N; Jere KC; Bennett A; Pollock L; Tate JE; Nakagomi O; Iturriza-Gomara M; Costello A; Mwansambo C; Parashar UD; Heyderman RS; French N; Cunliffe NA;
Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S213-9. PubMed ID: 27059359
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Pentavalent Rotavirus Vaccine Against a Diverse Range of Circulating Strains in Nicaragua.
Patel M; Pedreira C; De Oliveira LH; Tate J; Leshem E; Mercado J; Umaña J; Balmaceda A; Reyes M; Kerin T; McDonald S; Gentsch J; Bowen MD; Parashar U
Clin Infect Dis; 2016 May; 62 Suppl 2():S127-32. PubMed ID: 27059346
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.
Tate JE; Ngabo F; Donnen P; Gatera M; Uwimana J; Rugambwa C; Mwenda JM; Parashar UD
Clin Infect Dis; 2016 May; 62 Suppl 2():S208-12. PubMed ID: 27059358
[TBL] [Abstract][Full Text] [Related]
16. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.
Beres LK; Tate JE; Njobvu L; Chibwe B; Rudd C; Guffey MB; Stringer JS; Parashar UD; Chilengi R
Clin Infect Dis; 2016 May; 62 Suppl 2():S175-82. PubMed ID: 27059353
[TBL] [Abstract][Full Text] [Related]
17. Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children.
Sahakyan G; Grigoryan S; Wasley A; Mosina L; Sargsyan S; Asoyan A; Gevorgyan Z; Kocharyan K; Avagyan T; Lopman B; Vanyan A; Khactatryan S; Parashar UD; Cortese MM
Clin Infect Dis; 2016 May; 62 Suppl 2():S147-54. PubMed ID: 27059349
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
Gastañaduy PA; Steenhoff AP; Mokomane M; Esona MD; Bowen MD; Jibril H; Pernica JM; Mazhani L; Smieja M; Tate JE; Parashar UD; Goldfarb DM
Clin Infect Dis; 2016 May; 62 Suppl 2():S161-7. PubMed ID: 27059351
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method.
Cardellino A; Khawaja S; Sánchez Cruz E; Mast TC
Hum Vaccin Immunother; 2013 Jul; 9(7):1449-53. PubMed ID: 23571175
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of rotavirus vaccines in an Australian population: A case-control study.
Fathima P; Snelling TL; Gibbs RA
Vaccine; 2019 Sep; 37(41):6048-6053. PubMed ID: 31473003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
